1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 1, 1997
OMNICARE, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
----------------------------------------------
(State or other jurisdiction of incorporation)
1-8269 31-1001351
- -----------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
50 East River Center Boulevard, Covington, Kentucky 41011
-----------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (606) 291-6800
------------------------------------------------------------------
2
Item 5. OTHER EVENTS
On December 1, 1997, Omnicare, Inc. issued the following press release:
OMNICARE TO MAKE PRIVATE OFFERING OF $300 MILLION OF CONVERTIBLE
SUBORDINATED DEBENTURES
CINCINNATI, OHIO, DECEMBER 1, 1997 ... Omnicare, Inc. (NYSE:OCR) today
announced that it intends to raise approximately $300 million through a private
placement of convertible subordinated debentures due 2007. The debentures will
be unsecured, subordinated obligations, convertible into Omnicare common stock
and non-callable for a period of three years.
The Company intends to use the net proceeds of the offering for the
repayment of bank debt under its revolving credit facility, the funding of
potential acquisitions and other general corporate purposes.
The offering, which is subject to market and other conditions, will be made
within the United States only to qualified institutional buyers and accredited
investors, and outside the United States to non-U.S. investors. The securities
offered have not been registered under the Securities Act of 1933 or applicable
state securities laws, and may not be offered or sold in the United States
absent registration or an applicable exemption from the registration
requirements of the Securities Act and applicable state laws. This announcement
shall not constitute an offer to sell or a solicitation of an offer to buy
either the debentures or the common stock of Omnicare.
Omnicare is a leading independent provider of pharmacy and related
consulting services for long-term care facilities such as nursing homes,
retirement centers and other institutional health care facilities. Omnicare
currently provides pharmacy and related consulting services to approximately
434,000 residents in over 5,400 long-term care facilities and other
institutional health care settings in 36 states.
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Omnicare, Inc.
-----------------------------
(Registrant)
/s/ DAVID W. FROESEL, JR.
By: -------------------------
Date: December 1, 1997 David W. Froesel, Jr.
Senior Vice President and
Chief Financial officer
(Principal Financial and
Accounting Officer)